Table 1 Age-standardized mortality and incidence rates, by cancer site, 1993–2013
From: The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013
Cancer site | Both sexes | Female | Male | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mortality | Incidence | Mortality | Incidence | Mortality | Incidence | ||||||||||
1993 | 2003 | 2013 | 2002 | 2012 | 1993 | 2003 | 2013 | 2002 | 2012 | 1993 | 2003 | 2013 | 2002 | 2012 | |
C00–97, B21 all cancers | 73.7 | 73.0 | 62.3 | 147.3 | 131.9 | 72.4 | 69.0 | 59.9 | 150.0 | 139.9 | 75.0 | 77.0 | 64.7 | 144.5 | 123.9 |
C00–14 lip, oral cavity and pharynx | 1.2 | 1.1 | 1.0 | 3.4 | 3.2 | 0.7 | 0.7 | 0.6 | 2.2 | 2.2 | 1.6 | 1.5 | 1.3 | 4.5 | 4.1 |
C15 oesophagus | 1.2 | 1.2 | 0.9 | 1.5 | 1.1 | 0.6 | 0.5 | 0.4 | 0.8 | 0.5 | 1.8 | 1.8 | 1.4 | 2.2 | 1.6 |
C16 stomach | 7.7 | 6.4 | 4.7 | 11.3 | 7.0 | 6.4 | 5.3 | 4.0 | 9.4 | 6.0 | 9.0 | 7.4 | 5.3 | 13.1 | 7.9 |
C18–21 colon, rectum and anus | 3.0 | 3.6 | 4.4 | 7.5 | 7.8 | 2.9 | 3.4 | 3.8 | 7.0 | 6.7 | 3.0 | 3.8 | 4.9 | 7.9 | 8.9 |
C25 pancreas | 3.7 | 3.3 | 4.7 | 3.9 | 3.6 | 3.3 | 4.7 | 3.8 | 3.8 | 3.3 | 4.6 | 3.9 | |||
C33–34 lung (incl. trachea and bronchus) | 10.3 | 8.8 | 5.7 | 11.9 | 7.7 | 5.2 | 4.9 | 3.8 | 6.7 | 4.9 | 15.4 | 12.7 | 7.6 | 17.0 | 10.5 |
C43 melanoma of skin | 0.4 | 0.5 | 0.5 | 1.6 | 1.8 | 0.3 | 0.3 | 0.4 | 1.7 | 1.5 | 0.4 | 0.6 | 0.5 | 1.4 | 2.1 |
C50 breast | 4.3 | 4.5 | 4.5 | 13.2 | 17.7 | 8.6 | 9.0 | 9.0 | 26.4 | 35.4 | |||||
C53 cervix uteri | 6.9 | 5.0 | 3.1 | 14.8 | 11.7 | 13.7 | 9.9 | 6.1 | 29.5 | 23.3 | |||||
C56 ovary | 1.7 | 1.7 | 3.7 | 2.8 | 3.3 | 3.4 | 7.4 | 5.6 | |||||||
C61 prostate | 4.9 | 6.1 | 5.0 | 15.0 | 13.7 | 9.8 | 12.1 | 10.0 | 29.9 | 27.3 | |||||
C64 kidney | 1.9 | 1.8 | 4.7 | 3.6 | 1.3 | 1.3 | 4.0 | 2.5 | 2.5 | 2.3 | 5.4 | 4.6 | |||
C70–72 brain, central nervous system | 2.0 | 1.8 | 3.0 | 4.0 | 1.6 | 1.5 | 2.4 | 3.3 | 2.3 | 2.1 | 3.5 | 4.6 | |||
C73 thyroid | 0.6 | 0.6 | 3.4 | 2.6 | 0.7 | 0.7 | 5.7 | 3.9 | 0.4 | 0.4 | 1.0 | 1.3 | |||
C81 hodgkin lymphoma | 0.5 | 0.4 | 1.7 | 1.3 | 0.4 | 0.3 | 1.2 | 1.1 | 0.6 | 0.5 | 2.1 | 1.5 | |||
C82–85, C96 non-Hodgkin lymphoma | 2.1 | 2.0 | 4.8 | 4.1 | 1.8 | 1.6 | 3.9 | 3.6 | 2.3 | 2.3 | 5.7 | 4.6 | |||
C88 + C90 multiple myeloma | 1.0 | 1.0 | 1.4 | 1.3 | 0.8 | 0.9 | 1.2 | 1.1 | 1.1 | 1.1 | 1.6 | 1.4 | |||
C91–95 leukemia | 3.2 | 3.7 | 3.3 | 5.0 | 5.6 | 2.9 | 3.3 | 3.0 | 4.3 | 5.1 | 3.4 | 4.1 | 3.6 | 5.6 | 6.0 |